2017年

英語論文

  1. Wang L, Hirohashi Y, Ogawa T, Shen M, Takeda R, Murai A, Yamamoto E, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Nishidate T, Okita K, Kutomi G, Sato N, Takemasa I, Torigoe T. , LY6/PLAUR domain containing 3 has a role in the maintenance of colorectal cancer stem-like cells., Biochem Biophys Res Commun., 486, 2, 232-238, 2017, 4, PMID:28238780
  2. Takeda R, Hirohashi Y, Shen M, Wang L, Ogawa T, Murai A, Yamamoto E, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Nishidate T, Okita K, Kutomi G, Sato N, Takemasa I, Torigoe T., Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells., Biochem Biophys Res Commun. , 485, 3, 651-657, 2017, 4, PMID:28219643
  3. Kanno S, Nosho K, Ishigami K, Yamamoto I, Koide H, Kurihara H, Mitsuhashi K, Shitani M, Motoya M, Sasaki S, Tanuma T, Maguchi H, Hasegawa T, Kimura Y, Takemasa I, Shinomura Y, Nakase H., MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer., Carcinogenesis., 38, 4, 425-431, 2017, 4, PMID:28186267
  4. Yasui M, Takemasa I, Miyake Y, Hata T, Ikeda M, Miyake Y, Hasegawa J, Ota H, Matsuda C, Mizushima T, Doki Y, Mori M; Clinical Study Group of Osaka University (CSGO), Colorectal Group., Tumor Size as an Independent Risk Factor for Postoperative Complications in Laparoscopic Low Anterior Resection for Advanced Rectal Cancer: A Multicenter Japanese Study., Surg Laparosc Endosc Percutan Tech., 27, 2, 98-103, 2017, 4, PMID:28141746
  5. Kitahara T, Haraguchi N, Takahashi H, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M., Identification and Characterization of CD107a as a Marker of Low Reactive Oxygen Species in Chemoresistant Cells in Colorectal Cancer., Ann Surg Oncol., 24, 4, 1110-1119, 2017, 4, PMID:27834032
  6. Takemoto H, Nishimura J, Komori T, Kim HM, Ota H, Suzuki R, Ikenaga M, Ikeda M, Yamamoto H, Satoh T, Hata T, Takemasa I, Mizushima T, Doki Y, Mori M;, Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO).., Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea., Int J Clin Oncol., 22, 1, 88-95 2017, 4, PMID:27465476
  7. Kubo, Hirohashi Y, Matsuo K, Sonoda T, Sakamoto H, Furumura K, Tsukahara T, Kanaseki T, Nakatsugawa M, Hirano H, Furuhata T, Takemasa I, Hasegawa T, Torigoe T., Mismatch Repair Protein Deficiency Is a Risk Factor for Aberrant Expression of HLA Class I Molecules: A Putative “Adaptive Immune Escape” Phenomenon., Anticancer Res., 37, 3, 1289-1295, 2017, 5, PMID:28314294
  8. Yamamoto I, Nosho K, Kanno S, Igarashi H, Kurihara H, Ishigami K, Ishiguro K, Mitsuhashi K, Maruyama R, Koide H, Okuda H, Hasegawa T, Sukawa Y, Okita K, Takemasa I, Yamamoto H, Shinomura Y, Nakase H., EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics., Oncotarget., 8, 11, 17810-17818, 2017, 5, PMID:28147317 | PMCID:PMC5392288
  9. Miyake Y, Nishimura J, Takahashi H, Haraguchi N, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M., The short-term outcomes of laparoscopic multivisceral resection for locally advanced colorectal cancer: our experience of 39 cases., Surg Today., 47, 5, 575-580, 2017, 5, PMID:27770208
  10. Sato Y, Ohnuma H, Nobuoka T, Hirakawa M, Sagawa T, Fujikawa K, Takahashi Y, Shinya M, Katsuki S, Takahashi M, Maeda M, Okagawa Y, Naoki U, Kikuch S, Okamoto K, Miyamoto H, Shimada M, Takemasa I, Kato J, Takayama T., Erratum to: Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study., Gastric Cancer., 20, 3, 527, 2017, 5, PMID:27629880
  11. Sato Y, Ohnuma H, Nobuoka T, Hirakawa M, Sagawa T, Fujikawa K, Takahashi Y, Shinya M, Katsuki S, Takahashi M, Maeda M, Okagawa Y, Naoki U, Kikuch S, Okamoto K, Miyamoto H, Shimada M, Takemasa I, Kato J, Takayama T., Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study., Gastric Cancer., 20, 3, 517-526, 2017, 5, PMID:27553665
  12. Hata T, Mizushima T, Osawa H, Takahashi H, Haraguchi N, Nishimura J, Hata T, Takemasa I, Ikenaga M, Nakajima K, Yamamoto H, Murata K, Doki Y, Mori M., Short-term outcomes of laparoscopic surgery for Crohn’s disease patients treated with anti-tumor necrosis factor alpha agents., Surg Today., 47, 3, 320-327, 2017, 5, PMID:27372080
  13. Ota H, Ikenaga M, Hasegawa J, Murata K, Miyake Y, Mizushima T, Hata T, Takemasa I, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M., Safety and efficacy of an “enhanced recovery after surgery” protocol for patients undergoing colon cancer surgery: a multi-institutional controlled study., Surg Today., 47, 6, 668-675, 2017, 6, PMID:27688031
  14. Hata T, Takemasa I, Takahashi H, Haraguchi N, Nishimura J, Hata T, Mizushima T, Doki Y, Mori M., Downregulation of serum metabolite GTA-446 as a novel potential marker for early detection of colorectal cancer., Br J Cancer., 117, 2, 227-232, 2017, 7, PMID:28632728 | PMCID:PMC5520513
  15. Miyo M, Takemasa I, Ishihara H, Hata T, Mizushima T, Ohno Y, Doki Y, Mori M., Long-term Outcomes of Single-Site Laparoscopic Colectomy With Complete Mesocolic Excision for Colon Cancer: Comparison With Conventional Multiport Laparoscopic Colectomy Using Propensity Score Matching., Dis Colon Rectum., 60, 7, 664-673, 2017, 7, PMID:28594715
  16. Okamura R, Yamaguchi T, Akagi T, Konishi T, Yamamoto M, Ota M, Matoba S, Bando H, Goto S, Sakai Y, Watanabe M; Japan Society of Laparoscopic Colorectal Surgery, Watanabe K, Otsuka K, Takemasa I, Tanaka K, Ikeda M, Matsuda C, Fukuda M, Hasegawa J, Akamoto S, Shiozawa M, Tsuruta A, Akiyoshi T, Kato T, Tsukamoto S,Ito M, Naito M, Kanazawa A, Takahashi T, Ueki T, Hayashi Y, Morita S, Yamaguchi T, Nakanishi M, Hasegawa H, Okamoto K, Teraishi F, Sumi Y, Tashiro J, Yatsuoka T, Nishimura Y, Okita K, Kobatake T, Horie H, Miyakura Y, Ro H, Nagakari K, Hidaka E, Umemoto T, Nishigori H, Murata K, Wakayama F, Makizumi R, Fujii S, Sunami E, Kobayashi H, Nakagawa R, Enomoto T, Ohnuma S, Higashijima J, Ozawa H, Ashida K, Fujita F, Uehara K, Maruyama S, Ohyama M, Yamamoto S, Hinoi T, Yoshimitsu M, Okajima M, Tanimura S, Kawasaki M, Ide Y, Hazama S, Watanabe J, Inagaki D, Toyokawa A, Local control of sphincter-preserving procedures and abdominoperineal resection for locally advanced low rectal cancer: Propensity score matched analysis., Ann Gastroenterol Surg., 1, 3, 199-207, 2017, 8, PMID:29863157 | PMCID:PMC5881346
  17. Yamauchi S, Yamano T, Yamauchi S, Kimura K, Babaya A, Hamanaka M, Kobayashi M, Fukumoto M, Tsukamoto K, Noda M, Tomita N, Sugihara K; Japanese Study Group for Postoperative Follow-up of Colorectal Cancer.., Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: A retrospective multicentre study., Eur J Cancer., 81, 90-101, 2017, 8, PMID:28622612
  18. Takeyama H, Mizushima T, Uemura M, Haraguchi N, Nishimura J, Hata T, Matsuda C, Takemasa I, Ikenaga M, Murata K, Yamamoto H, Doki Y, Mori M., Adipose-Derived Stem Cells Ameliorate Experimental Murine Colitis via TSP-1-Dependent Activation of Latent TGF-β., Dig Dis Sci., 62, 8, 1963-1974, 2017, 8, PMID:28434074
  19. Miyo M, Takemasa I, Ikeda M, Tujie M, Hasegawa J, Ohue M, Kato T, Mizushima T, Doki Y, Mori M., The influence of specific technical maneuvers utilized in the creation of diverting loop-ileostomies on stoma-related morbidity., Surg Today., 47, 8, 940-950, 2017, 8, PMID:28280983
  20. Takahashi H, Takemasa I, Haraguchi N, Nishimura J, Hata T, Yamamoto H, Matsuda C, Mizushima T, Doki Y, Mori M., The single-center experience with the standardization of single-site laparoscopic colectomy for right-sided colon cancer., Surg Today., 47, 8, 966-972 2017, 8, PMID:27999950
  21. Kanzaki R, Inoue M, Kimura T, Kawamura T, Funaki S, Shintani Y, Minami M, Takemasa I, Mizushima T, Mori M, Okumura M., Role of pulmonary metastasectomy in colorectal cancer in the era of modern multidisciplinary therapy., Surg Today., 47, 9, 1111-1118, 2017, 9, PMID:28205021
  22. Ogawa T, Hirohashi Y, Murai A, Nishidate T, Okita K, Wang L, Ikehara Y, Satoyoshi T, Usui A, Kubo T, Nakastugawa M, Kanaseki T, Tsukahara T, Kutomi G, Furuhata T, Hirata K, Sato N, Mizuguchi T, Takemasa I, Torigoe T., ST6GALNAC1 plays important roles in enhancing cancer stem phenotypes of colorectal cancer via the Akt pathway., Oncotarget., 8, 68, 112550-112564, 2017, 11, PMID:29348846 | PMCID:PMC5762531
  23. Miyo M, Takemasa I, Ishihara H, Hata T, Mizushima T, Ohno Y, Doki Y, Mori M., The Author Replies., Dis Colon Rectum., 60, 11, e631-e632 2017, 11, PMID:28991091
  24. Hata T, Takahashi H, Sakai D, Haraguchi N, Nishimura J, Kudo T, Chu M, Takemasa I, Taroh S, Mizushima T, Doki Y, Mori M., Neoadjuvant CapeOx therapy followed by sphincter-preserving surgery for lower rectal cancer., Surg Today., 47, 11, 1372-1377, 2017, 11, PMID:28474202
  25. Miyo M, Konno M, Colvin H, Nishida N, Koseki J, Kawamoto K, Tsunekuni K, Nishimura J, Hata T, Takemasa I, Mizushima T, Doki Y, Mori M, Ishii H., The importance of mitochondrial folate enzymes in human colorectal cancer., Oncol Rep., 37, 1, 417-425 2017, 11, PMID:27878282
  26. Yasui M, Ikeda M, Miyake M, Ide Y, Okuyama M, Shingai T, Kitani K, Ikenaga M, Hasegawa J, Akamatsu H, Murata K, Takemasa I, Mizushima T, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M; Clinical Study Group of Osaka University (CSGO), Colorectal Group.., Comparison of bleeding risks related to venous thromboembolism prophylaxis in laparoscopic vs open colorectal cancer surgery: a multicenter study in Japanese patients., Am J Surg., 213, 1, 43-49, 2017, 11, PMID:26772140
  27. Sato Y, Hirakawa M, Ohnuma H, Takahashi M, Okamoto T, Okamoto K, Miyamoto H, Muguruma N, Furuhata T, Takemasa I, Kato J, Takayama T., A triplet combination with capecitabine/oxaliplatin/irinotecan (XELOXIRI) plus cetuximab as first-line therapy for patients with metastatic colorectal cancer: a dose escalation study., Cancer Chemother Pharmacol., 80, 6, 1133-1139, 2017, 12, PMID:29038850
  28. Miyake Y, Mizushima T, Hata T, Takahashi H, Hanada H, Shoji H, Nomura M, Haraguchi N, Nishimura J, Matsuda C, Takemasa I, Doki Y, Maeda I, Mori M, Yamamoto H., Inspection of Perirectal Lymph Nodes by One-Step Nucleic Acid Amplification Predicts Lateral Lymph Node Metastasis in Advanced Rectal Cancer., Ann Surg Oncol., 24, 13, 3850-3856, 2017, 12, PMID:28924845
  29. Miyo M, Takemasa I, Hata T, Mizushima T, Doki Y, Mori M., Safety and Feasibility of Umbilical Diverting Loop Ileostomy for Patients with Rectal Tumor., World J Surg., 41, 12, 3205-3211, 2017, 12, PMID:28748422
  30. Miyake Y, Nishimura J, Kato T, Ikeda M, Tsujie M, Hata T, Takemasa I, Mizushima T, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M; Multi-center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO)., Phase III trial comparing UFT + PSK to UFT + LV in stage IIB, III colorectal cancer (MCSGO-CCTG), Surg Today., 48, 1, 66-72, 2018, 1, PMID:28634730
  31. Miyamoto S, Kochin V, Kanaseki T, Hongo A, Tokita S, Kikuchi Y, Takaya A, Hirohashi Y, Tsukahara T, Terui T, Ishitani K, Hata F, Takemasa I, Miyazaki A, Hiratsuka H, Sato N, Torigoe T., The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer., Cancer Immunol Res., Epub ahead of print, 2018, 1, PMID:29371260
  32. Ohnuma H, Sato Y, Hirakawa M, Kikuchi S, Miyanishi K, Sagawa T, Takahashi Y, Nobuoka T, Okamoto K, Miyamoto H, Takemasa I, Takayama T, Kato J., Docetaxel, cisplatin and S-1 (DCS) combination chemotherapy for gastric cancer patients with peritoneal metastasis: a retrospective study., Cancer Chemother Pharmacol., 81, 3, 539-548, 2018, 1, PMID:29383482
  33. Uemura M, Ikeda M, Kawai K, Nishimura J, Takemasa I, Mizushima T, Yamamoto H, Sekimoto M, Doki Y, Mori M., Laparoscopic surgery using a Gigli wire saw for locally recurrent rectal cancer with concomitant intraperitoneal sacrectomy., Asian J Endosc Surg., 11, 1, 83-86, 2018, 2, PMID: 29485249
  34. Nishizawa Y, Hata T, Takemasa I, Yamasaki M, Akasaka H, Sugimoto K, Tamai K, Takahashi H, Haraguchi N, Nishimura J, Matsuda C, Mizushima T, Ikenaga M, Yamamoto H, Murata K, Rakugi H, Doki Y, Mori M., Clinical benefits of single-incision laparoscopic surgery for postoperative delirium in elderly colon cancer patients., Surg Endosc., 32, 3, 1434-1440, 2018, 3, PMID:29075972
  35. Niinuma T, Kai M, Kitajima H, Yamamoto E, Harada T, Maruyama R, Nobuoka T, Nishida T, Kanda T, Hasegawa T, Tokino T, Sugai T, Shinomura Y, Nakase H, Suzuki H, Downregulation of miR-186 is associated with metastatic recurrence of gastrointestinal stromal tumors., Oncol Lett., 14, 5, 5703-5710, 2017
  36. Zembutsu H, Onishi H, Udagawa C, Kubo M, Nakamura S, Akashi-Tanaka S, Kuwayama T, Watanabe C, Takamaru T, Takei H, Ishikawa T, Miyahara K, Matsumoto H, Hasegawa Y, Momozawa Y, Low SK, Kutomi G, Shima H, Satomi F, Okazaki M, Zaha H, Onomura M, Matsukata A, Sagara Y, Baba S, Yamada A, Shimada K, Shimizu D, Tsugawa K, Shimo A, Hartman M, Chan CW, Lee SC, Endo I, Zembutsu H., A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study., PLoS One, 13, 8, e0201606, 2018
  37. Nagayama M, Mizuguchi T, Yamaguchi H, Imamura M, Kutomi G, Okita K, Nishidate T, Takemasa I, Kimura Y, Technical aspects and surgical complications of laparoscopic liver resection., Ann Laparosc Endosc Surg, 2, 61, 2017
  38. Kutomi G, Mizuguchi T, Satomi F, Maeda H, Shima H, Kimura Y, Hirata K., Current status of the prognostic molecular biomarkers in breast cancer: A systematic review., Oncol Lett., 13, 3, 1491-8, 2017
  39. Manzanares, Campbell DJ, Dumur CI, Maldonado GT, Fausther M, Dranoff JA, Sirica AE, Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model., Am J Pathol., 187, 5, 1068-1092, 2017
  40. Hamabe A, Ito M, A three-dimensional pelvic model made with a three-dimensional printer: applications for laparoscopic surgery to treat rectal cancer, Tech Coloproctol, 21, 5, 383-387, 2017
  41. Yamaguchi H, Kimura Y, Imamura M, Nagayama M, Ito T, Nobuoka T, Mizuguchi T, Takemasa I, Oncological Features and Outcomes of Curatively Resected Non-Functional Pancreatic Neuroendocrine Tumor: Single Institute Experiences, Journal of the Pancreas, 18, 5, 335-338 2017
  42. Ishii M, Kino J, Ichinohe N, Tanimizu N, Ninomiya T, Suzuki H, Mizuguchi T, Hirata K, Mitaka T., Hepatocytic parental progenitor cells of rat small hepatocytes maintain self-renewal capability after long-term culture., Sci Rep., 11, 7, 2017
  43. Tatsumi H, Yoshiki Masuda, Kanako Takahashi, Maiko Honma, Shinichiro Yoshida, Michihiro Ono, Masayo Motoya, Yasutoshi Kimura, Michiaki Yamakage, Usefulness of plasma exchange for hypertriglyceridemia-induced severe acute pancreatitis: report of three cases., J Clin Case Stu, 2, 2, doi http://dx.doi.org/10.16966/2471-4925.143, 2017
  44. Chihara S, Yoshiki Masuda, Hiroomi Tatsumi, Kota Nakano, Tomokazu Shimada, Takao Murohashi, Michiaki Yamakage, Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock., J Artif Organs, 20, 1, 71-75, 2017
  45. Akatsuka M, Tatsumi H, Kuroda H, Otsuki I, Toyohara T, Masuda Y, A case of of cardiopulmonary resuscitation-indced liver injury., Anesth Resus, 53, 3, 59-60, 017
  46. Nishida O, Ogura H, Egi M, Fujishima S, Hayashi Y, Iba T, Imaizumi H, Inoue S, Kakihana Y, Kotani J, Kushimoto S, Masuda Y, Matsuda N, Matsushima A, Nakada T, Nakagawa S, Nunomiya S, Sadahiro T, Shime N, Yatabe T, Hara Y, Hayashida K, Kondo Y, Sumi T, Yasuda H, Aoyama K, Azuhata T, Doi K, Doi M, Fujimura N, Fuke R, Fukuda T, Goto K, Hasegawa R, Hashimoto S, Hatakeyama J, Hayakawa, M Hifumi T, Higashibeppu N, Hirai K, Hirose T, Ide K, Kaizuka Y, Kan’o T, Kawasaki T, Kuroda H, Matsuda A, Matsumoto S, Nagae M, Onodera M, Ohnuma T, Oshima, K Saito N, Sakamoto S, Sakuraya M, Sasano M, Sato N, Sawamura A, Shimizu K, Shirai K, Takei T, Takeuchi M, Takimoto K, Taniguchi T, Tatsumi H, Tsuruta R, Yama N, Yamakawa K, Yamashita C, Yamashita K, Yoshida T, Tanaka H, Oda S, The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016), Journal of Intensive Care, 6, 7, 2018
  47. Nishida O, Ogura H, Egi M, Fujishima S, Hayashi Y, Iba T, Imaizumi H, Inoue S, Kakihana Y, Kotani J, Kushimoto S, Masuda Y, Matsuda N, Matsushima A, Nakada TA, Nakagawa S, Nunomiya S, Sadahiro T, Shime N, Yatabe T, Hara Y, Hayashida K, Kondo Y, Sumi Y, Yasuda H, Aoyama K, Azuhata T, Doi K, Doi M, Fujimura N, Fuke R, Fukuda T, Goto K, Hasegawa R, Hashimoto S, Hatakeyama J, Hayakawa M, Hifumi T, Higashibeppu N, Hirai K, Hirose T, Ide K, Kaizuka Y, Kan’o T, Kawasaki T, Kuroda H, Matsuda A, Matsumoto S, Nagae M, Onodera M, Ohnuma T, Oshima K, Saito N, Sakamoto S, Sakuraya M, Sasano M, Sato N, Sawamura A, Shimizu K, Shirai K, Takei T, Takeuchi M, Takimoto K, Taniguchi T, Tatsumi H, Tsuruta R, Yama N, Yamakawa K, Yamashita C, Yamashita K, Yoshida T, Tanaka H, Oda S., The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016), Acute Med Surg, 5, 5, 3-89, 2018
  48. Bunya N, Harada K, Kuroda Y, Tohoyara T, Kubota N, Kakizaki R, Irifune H, Uemura S, Narimatsu E., The effectiveness of hybrid treatment for severe multiple trauma: a case report of multiple trauma for damage control laparotomy and thoracic endovascular repair., Int J Emerg Med, 10, 18, 1-5 2017

邦文総説・著書

  1. 竹政 伊知朗, 超音波凝固切開装置 LCSを用いたS状結腸切除手術手技について, 日本内視鏡外科学会雑誌(1344-6703), 22, 7, Page ES2-2, 2017, 2018142453
  2. 竹政 伊知朗, 沖田 憲司, 西舘 敏彦, 植木 知身, 秋月 恵美, 碓井 彰大, 石井 雅之, 里吉 哲太, 【再確認しよう! 内視鏡外科の基本手技;体位からデバイスの使用法まで】 体位からデバイスの使用法まで 7.剥離・授動、リンパ節郭清操作, 消化器外科(0387-2645), 40, 8, Page1189-1198, 2017, 2017336160
  3. 竹政 伊知朗, 【直腸早期癌-治療の新たな展開】 TAMIS(transanal minimally invasive surgery) 局所切除, Intestine(1883-2342), 94, 3, Page241-248, 2017, 2017315011
  4. 竹政 伊知朗, 【特集 百花繚乱! エネルギーデバイスを使いこなす】術式別:デバイスの選択と活用法 腹腔鏡下右側結腸癌手術ー超音波凝固切開装置を用いて, 臨床外科(0386-9857), 72, 5, Page562-568, 2017, 2017209230
  5. 竹政 伊知朗, 第22回日本内視鏡外科学会教育セミナーⅡ テーマ:技術認定審査のポイント:大腸, 日本内視鏡外科学会雑誌, 22, 7, Page3253-3256, 2017
  6. 沖田 憲司, 竹政 伊知朗, 西舘 敏彦, 秋月 恵美, 碓井 彰大, 石井 雅之, 【究極のこだわり 直腸癌に対する腹腔鏡下手術】 transanal-TME(ISR), 消化器外科(0387-2645), 40, 13, Page1809-1816, 2017, 2018064227
  7. 沖田 憲司, 西舘 敏彦, 竹政 伊知朗, 【外科手術器具の理論と使用法】III.エネルギーデバイス 下部消化管手術で用いるエネルギーデバイス, 外科(0016-593X), 79, 12, Page1175-1178, 2017, 2018047821
  8. 沖田 憲司, 西舘 敏彦, 奥谷 浩一, 秋月 恵美, 碓井 彰大, 竹政 伊知朗, 【合併症ゼロを目指した最新の低侵襲内視鏡外科手術】 大腸・肛門 腹腔鏡下S状結腸切除術, 手術(0037-4423), 72, 4, Page595-601, 2018, 2018209080
  9. 小山 奈緒美, 山 直也, 小野寺 麻希, 小野寺 耕一, 大塚 愛子, 大沼 ゆりな, 畠中 正光, 木村 康利, 竹政 伊知朗, 長谷川 匡, ちょっと気になる胆・膵画像 ティーチングファイルから(第38回) 膵神経内分泌腫瘍の診断 ソマトスタチン受容体シンチグラフィー、他モダリティーを用いた画像診断, 胆と膵(0388-9408), 39, 2, Page107-110, 2018, 2018170275
  10. 信岡 隆幸, 竹政 伊知朗, 胃癌治療ガイドライン, 北海道外科雑誌(0288-7509), 62, 1, Page19-22, 2017, 2018029551
  11. 信岡 隆幸, 竹政 伊知朗, 胃癌 胃癌治療ガイドライン, 日本外科学会雑誌(0301-4894), 118, 3, Page373-374, 2017, 2017259158
  12. 西舘 敏彦, 竹政 伊知朗, 沖田 憲司, 秋月 恵美, 碓井 彰大, 石井 雅之, 【直腸癌に対する経肛門アプローチのすべて】 経肛門的直腸間膜全切除術(taTME), 手術(0037-4423), 71, 12, Page1631-1638, 2017, 2018059628
  13. 西舘 敏彦, 竹政 伊知朗, 【この合併症(ジケン)も食い止めろ!危険サインを見逃すな!続・こちら合併症探偵局】 断たれた退路(腸閉塞), 消化器外科Nursing(1341-7819), 22, 11, Page1034-1037, 2017, 2018027576
  14. 木村 康利, 今村 将史, 永山 稔, 目黒 誠, 竹政 伊知朗, 【診断と治療のABC[121]胆石症・胆管結石 胆道炎・胆道がん】 (第2章)胆道炎 急性胆嚢炎・胆管炎の外科治療, 最新医学(0370-8241)別冊胆石症・胆管結石・胆道炎・胆道がん, Page111-118, 2017, 2017319610
  15. 巽 博臣, 升田好樹, 特集「重症感染症の集中治療―成功に導く管理ポイント」.栄養管理のポイント., 医事新報, 4866, 57-64, 2017
  16. 日本集中治療医学会重症患者の栄養管理ガイドライン作成委員会, 小谷穣治、江木盛時、海塚安郎、亀井有子、神應知道、木下浩作、佐藤格夫、清水孝宏、清水義之、志馬伸朗、白井邦博、巽 博臣、西田 修、東別府直紀、松田兼一、真弓俊彦、平澤博之、氏家良人, 日本版重症患者の栄養療法ガイドライン:病態別栄養療法., 日集中医誌, 24, 5, 569-591, 2017
  17. 巽 博臣, 黒田浩光, 特集「エキスパートに学ぶ栄養管理のすべて」.ベーシック編.経腸栄養耐性の評価方法と腸管蠕動改善薬の意義と効果., 救急集中治療, 30, 1, 39-46, 2018
  18. 巽 博臣, 赤塚正幸, 特集「エキスパートに学ぶ栄養管理のすべて」.アドバンス編-重症患者の栄養管理をワンランクアップさせるために-.肝不全., 救急集中治療, 30, 1, 119-123, 2018
  19. 巽 博臣, 第 2 章 栄養管理の実際:成人.D.経腸栄養耐性の評価.1.腸管蠕動の確認., 日本版 重症患者の栄養療法ガイドライン総論2016&病態別2017 ダイジェスト版.小谷穣治、東別府直紀編.真興交易株式会社医書出版部,東京., P63, 2018
  20. 巽 博臣, 升田好樹, 第 2 章 栄養管理の実際:成人.D.経腸栄養耐性の評価.2.経腸栄養耐性の評価方法., 日本版 重症患者の栄養療法ガイドライン総論2016&病態別2017 ダイジェスト版.小谷穣治、東別府直紀編.真興交易株式会社医書出版部,東京., P64-65, 2018
  21. 巽 博臣, 第 2 章 栄養管理の実際:成人.D.経腸栄養耐性の評価.3.経腸栄養投与量の増量の方法., 日本版 重症患者の栄養療法ガイドライン総論2016&病態別2017 ダイジェスト版.小谷穣治、東別府直紀編.真興交易株式会社医書出版部,東京., P66, 2018
  22. 巽 博臣, 第 2 章 栄養管理の実際:成人.D.経腸栄養耐性の評価.4.経腸栄養と誤嚥., 日本版 重症患者の栄養療法ガイドライン総論2016&病態別2017 ダイジェスト版.小谷穣治、東別府直紀編.真興交易株式会社医書出版部,東京. , P67-73, 2018
  23. 巽 博臣, 第 2 章 栄養管理の実際:成人.D.経腸栄養耐性の評価.5.下痢の発生時の対応., 日本版 重症患者の栄養療法ガイドライン総論2016&病態別2017 ダイジェスト版.小谷穣治、東別府直紀編.真興交易株式会社医書出版部,東京., P74-75, 2018
  24. 巽 博臣, 第 2 章 栄養管理の実際:成人.F.補足的治療.5.高脂肪/低炭水化物(high fat & low CHO)栄養剤., 日本版 重症患者の栄養療法ガイドライン総論2016&病態別2017 ダイジェスト版.小谷穣治、東別府直紀編.真興交易株式会社医書出版部,東京., P95-96, 2018
  25. 巽 博臣, 第 2 章 栄養管理の実際:成人.J.病態別栄養療法.3.肝不全., 日本版 重症患者の栄養療法ガイドライン総論2016&病態別2017 ダイジェスト版.小谷穣治、東別府直紀編.真興交易株式会社医書出版部,東京., P122-127, 2018

邦文原著

  1. 岩山 祐司, 九冨 五郎, 高丸 智子, 亀嶋 秀和, 大村 東生, 星川 剛, 平田 公一, 竹政 伊知朗, 術前TC療法によりpCRが得られた炎症性乳癌の一例, 臨牀と研究(0021-4965), 94, 6, Page747-751, 2017, 2017303792
  2. 川崎 浩之, 大村 東生, 亀嶋 秀和, 染谷 哲史, 平山 泰生, 浅石 和昭, 九冨 五郎, 竹政 伊知朗, 石谷 邦彦, 乳房温存術後に発生した放射線誘発性血管肉腫の1例, 日本外科系連合学会誌(0385-7883), 42, 4, Page743-751, 2017, 2018162164
  3. 前田 豪樹, 九冨 五郎, 里見 蕗乃, 島 宏彰, 宇野 智子, 長谷川 匡, 竹政 伊知朗, 両側共に特殊型の同時性両側乳癌の1例, 臨牀と研究(0021-4965), 94, 5, Page604-607, 2017, 2017300341
  4. 島 宏彰, 九冨 五郎, 木村 康利, 鳥越 俊彦, 竹政 伊知朗, サバイビン2B癌ペプチドワクチンにより長期生存を得た膵癌の1例, 手術(0037-4423), 71, 13, Page1807-1811, 2017, 2018120375
  5. 碓井 彰大, 山崎 一馬, 児玉 多曜, 近藤 悟, 北原 美由紀, 牧野 治文, 松原 久裕, 偶然発見された腹腔内異物性肉芽腫に対し、腹腔鏡下摘出術を施行した1例, 千葉医学雑誌, 3, 6, 241-246, 2017
  6. 升田好樹, 巽 博臣、黒田浩光、赤塚正幸、大槻郁人、相坂和貴子、高桑一登、門馬京子、吉田真一郎、今泉 均, Quick SOFAを用いたICU外での敗血症診断とSepsis-3による敗血症補助診断におけるプロカルシトニンのカットオフ値に及ぼす影響., エンドトキシン血症救命治療研究会誌, 21, 1, 59-62, 2017
  7. 千原伸也, 島田朋和、巽 博臣、中村勇輝、山口真依、小川輝之、升田好樹, 持続的血液濾過におけるヘモフィルタ素材と濾過流量の違いによるクリアランス特性の検討., 日急性血浄化会誌, 8, 2, 127-131 2017
  8. 巽 博臣, 升田好樹、髙橋科那子、本間舞子、数馬 聡、片山洋一、吉田真一郎、山蔭道明, 肺胞出血による呼吸不全、急性腎障害を合併した重症型顕微鏡的多発血管炎(MPA)の1救命例., 人工呼吸, 34, 2, 191-197, 2017